학술논문

The One Health Consortium: Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Combination With a Checkpoint Inhibitor in Canine Patients With Sporadic High Grade Gliomas
Document Type
Article
Source
In: Frontiers in Surgery. (Frontiers in Surgery, 28 August 2020, 7)
Subject
Language
English
ISSN
2296875X